Close
Nordic 9Nordic 9

Milad Alucozai (investor - Angel Investor)

United States
See something wrong or missing? Let us know
Offices:San Francisco

Milad Alucozai works for Entrepreneur First in USA

Average round investment:21.25M USD
Average number per year:1.0
Distribution: 2022 (1)2021 (1)
Portfolio companies: United Kingdom Ochre BioUnited Kingdom FabricNano
Mostly invests in: United Kingdom United Kingdom (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Milad Alucozai

Name Criteria
Hong Kong CR-CP Life Science Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Riyadh Valley Company
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Energy
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China GT Healthcare Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Rick Klausner
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan UTokyo IPC
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Emma Watson
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Energy
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Arvind Gupta
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Energy
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Alexander Moscho
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Energy
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom ALSA Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Walden Catalyst Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top